Immediate Impact
55 standout
Citing Papers
Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems
2024 Standout
Pharmacogenomics: current status and future perspectives
2023 Standout
Works of Earlene E. Lipowski being referenced
Evaluation of FDA safety‐related drug label changes in 2010
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Earlene E. Lipowski | 142 | 133 | 79 | 112 | 31 | 442 | |
| Paul Gavaza | 103 | 137 | 49 | 145 | 54 | 498 | |
| Henri R. Manasse | 101 | 309 | 44 | 85 | 60 | 446 | |
| Tim Schutte | 103 | 94 | 22 | 57 | 25 | 431 | |
| William H. Campbell | 68 | 105 | 36 | 67 | 44 | 387 | |
| Kieran Dalton | 95 | 382 | 34 | 160 | 34 | 511 | |
| Ivan Bindoff | 107 | 249 | 18 | 81 | 34 | 490 | |
| Marika Pohjanoksa-Mäntylä | 180 | 227 | 45 | 82 | 27 | 402 | |
| John Rovers | 165 | 245 | 38 | 47 | 32 | 506 | |
| Josep Maria Arnau | 58 | 158 | 30 | 65 | 17 | 455 | |
| Stephanie Taché | 133 | 153 | 14 | 56 | 17 | 426 |
All Works
Loading papers...